Since January 2016, Smith Anderson has advised clients in more than 300 transactions representing approximately $30 billion in value, including mergers, acquisitions and divestitures; real estate development and construction; life sciences and health care; technology and intellectual property; debt finance; private equity and mezzanine finance; initial public offerings; growth companies and venture capital; and fund formation. The following provides a comprehensive overview of some of our clients' key business transactions in 2016. Highlights include:
- Over 60 Mergers, Acquisitions and Public Offerings totaling approximately $22 billion, including the representation of Quintiles in its merger with IMS Health Holdings.
- Over 60 Life Sciences and Health Care transactions, including an immuno-oncology partnership worth up to $1.6 billion for genome editing company Precision BioSciences.
- Over 70 Debt Finance and more than 50 Private Equity and Mezzanine Finance transactions totaling more than $4 billion.
- Over 100 Real Estate and Construction matters totaling more than $2 billion.
- Over 60 Technology and Intellectual Property transactions totaling more than $3 billion, including the representation of Southern Company and PowerSecure, Inc. in their strategic alliance with Bloom Energy Corporation.
Our firm is fortunate to have worked on a wide array of transactions with a diverse group of clients. CLICK HERE to expand the image below, which lists some of our clients and their business transactions in 2016.
- Commercial Contracts
- Commercial Real Estate
- Corporate and Syndicated Finance
- Health Care
- Information Technology
- Intellectual Property
- Land Use and Zoning
- Life Sciences
- Mergers and Acquisitions
- Mezzanine Finance
- Private Equity
- Real Estate Development
- Venture Capital